Nichirei Corporation started their Bioscience business in 1983 as a manufacturer of Anti-Leukocytes Monoclonal antibodies (CD Antibodies). Their mission is to contribute to the development of the global Bio-industries including medical, cosmetic and healthcare business as a specialised company by offering high-quality products and services based on its advanced technology.
Through Nichirei Bio's state-of-the-art Universal Immuo-enzyme Polymer (UIP) method they are able to manufacture and supply CE marked N-Histofine products for Human, Mouse and Rat tissue. Also, Nichirei Bio manufactures and supplies several IVD products for IHC domestically.